However, to date, most FOXM1 expression studies in cancer, including ovarian cancer, have only reported overall FOXM1 protein levels rather than phosphorylated FOXM1 (phospho-FOXM1), which stems from a limited number of antibodies available for PTMs. The gene discussed is FOXM1; the disease is ovarian cancer.